In early 2020, the rapid global spread of Covid‑19 created an unprecedented public health crisis, driving governments, health organizations, and pharmaceutical companies to collaborate at extraordinary speed. One innovative company developed a breakthrough vaccine but then faced the immense challenge of producing and distributing billions of doses worldwide. Beyond scientific success, the urgency required a reliable and scalable logistics capability to ensure equitable and timely delivery. The company needed to manage the complexities of global distribution, including shipping temperature‑sensitive vaccines across diverse regions, while maintaining quality, safety, and speed to support the worldwide response to the pandemic.

Join for free to read